Clinical Trial Update: Oral Pyridoxal 5'-Phosphate for the Treatment of Patients With PNPO Deficiency [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral pyridoxal 5'-phosphate for pyridox(am)ine 5'-phosphate oxidase deficiency is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyridox Ine -phosphate Oxidase Deficiency

Drugs mentioned

• Pyridoxal 5'-phosphate (pyridoxal 5'-phosphate)

Snippet

Sponsor: Medicure | Conditions: Pyridox(am)Ine 5'-Phosphate Oxidase Deficiency | Phase 3 | Status: RECRUITING